Target intelligence / Profile preview

Cancer cell oncolysis

Molecular classification
Other
01

Overview

"Cancer cell oncolysis" describes the process by which cancer cells are destroyed, typically by the rupture (lysis) of their membranes. In the context of modern cancer therapy, it is often discussed with reference to **oncolytic virus therapy**: genetically engineered or naturally occurring viruses are designed to selectively infect and replicate in cancer cells, causing them to burst and die. This primary lytic effect can also stimulate an immune response against the tumor by exposing tumor-specific antigens. Oncolysis is not a specific protein, gene, or receptor, but is an important therapeutic mechanism and endpoint in cancer treatment.

Other names
oncolysiscancer cell lysistumor cell lysiscell lysis (non-specific)
02

Mechanism of action

Direct viral lysis of cancer cells\nIndirect activation of the immune response via release of tumor antigens\nAlteration of the tumor microenvironment to facilitate cell death and immune infiltration

03

Biological functions

Cell deathCancer cell destructionImmune activation (when linked with oncolytic virus therapy)
04

Disease associations

Cancer
05

Safety considerations

Potential for inflammation or off-target effects if normal tissue is infectedImmune-related adverse events due to viral or immune activationLimited therapy efficacy if the host immune system rapidly clears the virus before extensive oncolysis can occurPre-existing immunity to viral vectors can reduce effectiveness
06

Interacting drugs

Talimogene laherparepvec (T-VEC, Imlygic)

3 more in the full profile.

07

Biomarkers

Tumor-associated antigen releaseImmune cell infiltration (sometimes measured as an effect of oncolysis, not a marker for the "target")

Beyond the preview

Go deeper on Cancer cell oncolysis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer cell oncolysis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call